With biotechnological advancements, innovative omics technologies are constantly
emerging that have enabled researchers to access multi-layer information from the genome …

Tumour cells have exquisite flexibility in reprogramming their metabolism in order to support
tumour initiation, progression, metastasis and resistance to therapies. These reprogrammed …

Residual tumours that persist after radiotherapy often develop acquired radiation resistance,
increasing the risk of recurrence and metastasis while providing obstacles to re-irradiation …

Metastasis has long been understood to lead to the overwhelming majority of cancer-related
deaths. However, our understanding of the metastatic process, and thus our ability to …

Gastric cancer (GC) typically carries a poor prognosis as it is often diagnosed at a late stage.
Altered metabolism has been found to impact cancer outcomes and affect patients' quality of …

A major pharmacological assumption is that lowering disease-promoting protein levels is
generally beneficial. For example, inhibiting metastasis activator BACH1 is proposed to …

Circulating tumor cells (CTCs) are important biomarkers in cancer diagnosis. However, the
specific labeling of CTCs with high capture efficiency in whole blood remains a problem …

Cancer is a deadly disease that affects a cell's metabolism and surrounding tissues.
Understanding the fundamental mechanisms of metabolic alterations in cancer cells would …

The altered metabolism of tumor cells is a well-known hallmark of cancer and is driven by
multiple factors such as mutations in oncogenes and tumor suppressor genes, the origin of …

Context In the face of the growing global burden of cancer, there is increasing interest in
dietary interventions to mitigate its impacts. Pre-clinical evidence suggests that time …